Fortrea Holdings Inc. (FTRE) - What Are Brokerages Saying About This Stock?

Fortrea logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Analysts have a consensus “Hold” rating on Fortrea, with six buy, one strong-buy, four hold and two sell recommendations. The average 12-month price target is $24.23.
  • Recent analyst views were mixed: Barclays and Citigroup raised targets and maintained buy-oriented ratings, while Deutsche Bank upgraded Fortrea to buy; Mizuho downgraded it to underperform.
  • Fortrea beat quarterly expectations, reporting EPS of $0.28 versus $0.22 forecast and revenue of $691.5 million versus $671.6 million expected.
  • Interested in Fortrea? Here are five stocks we like better.

Shares of Fortrea Holdings Inc. (NASDAQ:FTRE - Get Free Report) have been assigned a consensus recommendation of "Hold" from the thirteen analysts that are covering the stock, MarketBeat.com reports. Two analysts have rated the stock with a sell rating, four have assigned a hold rating, six have assigned a buy rating and one has given a strong buy rating to the company. The average 12 month price objective among analysts that have issued a report on the stock in the last year is $24.23.

FTRE has been the subject of a number of research analyst reports. Barclays boosted their price target on Fortrea from $23.00 to $26.00 and gave the stock an "overweight" rating in a report on Friday, October 30th. Wall Street Zen lowered Fortrea from a "buy" rating to a "hold" rating in a research report on Saturday, October 31st. Deutsche Bank upgraded Fortrea from a "hold" rating to a "buy" rating and boosted their price target for the stock from $20.00 to $25.00 in a report on Thursday, October 15th. Citigroup raised their price objective on shares of Fortrea from $22.00 to $27.00 and gave the company a "buy" rating in a report on Friday, October 30th. Finally, Mizuho downgraded shares of Fortrea from a "neutral" rating to an "underperform" rating and lifted their target price for the stock from $16.00 to $19.00 in a research report on Wednesday, November 11th.

Check Out Our Latest Stock Analysis on FTRE

Fortrea Stock Down 1.9%

NASDAQ FTRE opened at $20.11 on Friday. The stock's 50 day simple moving average is $20.99 and its 200 day simple moving average is $16.01. The company has a debt-to-equity ratio of 1.94, a current ratio of 0.97 and a quick ratio of 0.97. Fortrea has a one year low of $8.55 and a one year high of $26.16. The firm has a market cap of $1.94 billion, a PE ratio of -27.54, a price-to-earnings-growth ratio of 0.50 and a beta of 1.88.

Fortrea (NASDAQ:FTRE - Get Free Report) last posted its earnings results on Thursday, October 29th. The company reported $0.28 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.22 by $0.06. The company had revenue of $691.50 million during the quarter, compared to analyst estimates of $671.57 million. Fortrea had a positive return on equity of 13.98% and a negative net margin of 2.58%. As a group, sell-side analysts forecast that Fortrea will post 0.86 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Fortrea

Several institutional investors and hedge funds have recently made changes to their positions in the business. Allworth Financial LP grew its stake in shares of Fortrea by 22.3% in the 2nd quarter. Allworth Financial LP now owns 3,923 shares of the company's stock valued at $68,000 after buying an additional 716 shares during the period. EverSource Wealth Advisors LLC increased its holdings in shares of Fortrea by 9.5% during the first quarter. EverSource Wealth Advisors LLC now owns 10,936 shares of the company's stock valued at $103,000 after acquiring an additional 953 shares in the last quarter. Ethic Inc. raised its position in shares of Fortrea by 7.4% during the third quarter. Ethic Inc. now owns 14,928 shares of the company's stock worth $298,000 after purchasing an additional 1,029 shares during the period. Financial Management Professionals Inc. acquired a new stake in Fortrea in the 3rd quarter valued at $30,000. Finally, Amundi increased its stake in Fortrea by 20.2% in the 1st quarter. Amundi now owns 12,490 shares of the company's stock valued at $118,000 after buying an additional 2,101 shares during the last quarter.

Fortrea Company Profile

(Get Free Report)

Fortrea Holdings Inc. is a global contract research organization that provides clinical development and patient access services to pharmaceutical, biotechnology and medical device companies. The company supports the development of medicines and medical products from early research through later-stage clinical trials and post-approval studies. Its services include clinical trial planning and management, clinical pharmacology, patient recruitment and engagement, data management, regulatory support and related consulting.

Further Reading

Analyst Recommendations for Fortrea (NASDAQ:FTRE)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Fortrea Right Now?

Before you consider Fortrea, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Fortrea wasn't on the list.

While Fortrea currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines